Antitope's Merger

Antitope raised a round of funding on July 29, 2013. Investors include Abzena.

Antitope is focused on providing services and technologies to enable the development of better biopharmaceuticals. Antitope was formed in Cambridge, UK, in 2004 in order to advance the research of the…

Articles about Antitope's Merger: